Search This Blog

Wednesday, July 1, 2026

Abivax prices its oversubscribed and upsized $800M ADS offering

 

Abivax prices its oversubscribed and upsized $800M ADS offering at $125 per share, boosting gross proceeds and extending its cash runway into Q2 2029

  • Abivax earlier halted Paris trading to finalize allocations and pricing for its ongoing U.S. ADS public offering.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)